Literature DB >> 8103151

Gene deletion: a new target for cancer chemotherapy.

E Frei1.   

Abstract

Entities:  

Mesh：

Year:  1993        PMID： 8103151     DOI： 10.1016/0140-6736(93)91764-d

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

1.  Choosing anticancer drug targets in the postgenomic era.

Authors:  W G Kaelin
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

Review 2.  Targeting Splicing in the Treatment of Myelodysplastic Syndromes and Other Myeloid Neoplasms.

Authors:  Charlotte K Brierley; David P Steensma
Journal:  Curr Hematol Malig Rep       Date:  2016-12       Impact factor: 3.952

Review 3.  Therapy-related myeloid neoplasms: when genetics and environment collide.

Authors:  Megan E McNerney; Lucy A Godley; Michelle M Le Beau
Journal:  Nat Rev Cancer       Date:  2017-08-24       Impact factor: 60.716

4.  Cancer prevention: accomplishments and prospects.

Authors:  P Cole; Y Amoateng-Adjepong
Journal:  Am J Public Health       Date:  1994-01       Impact factor: 9.308

5.  BCL3 expression promotes resistance to alkylating chemotherapy in gliomas.

Authors:  Longtao Wu; Giovanna M Bernal; Kirk E Cahill; Peter Pytel; Carrie A Fitzpatrick; Heather Mashek; Ralph R Weichselbaum; Bakhtiar Yamini
Journal:  Sci Transl Med       Date:  2018-07-04       Impact factor: 17.956

6.  Cancer vulnerabilities unveiled by genomic loss.

Authors:  Deepak Nijhawan; Travis I Zack; Yin Ren; Matthew R Strickland; Rebecca Lamothe; Steven E Schumacher; Aviad Tsherniak; Henrike C Besche; Joseph Rosenbluh; Shyemaa Shehata; Glenn S Cowley; Barbara A Weir; Alfred L Goldberg; Jill P Mesirov; David E Root; Sangeeta N Bhatia; Rameen Beroukhim; William C Hahn
Journal:  Cell       Date:  2012-08-17       Impact factor: 41.582

Review 7.  Targeting the transcription cycle and RNA processing in cancer treatment.

Authors:  Lin Zhang; Youyou Zhang; Xiaowen Hu
Journal:  Curr Opin Pharmacol       Date:  2021-05-05       Impact factor: 4.768

8.  Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDS.

Authors:  Jan Krönke; Emma C Fink; Paul W Hollenbach; Kyle J MacBeth; Slater N Hurst; Namrata D Udeshi; Philip P Chamberlain; D R Mani; Hon Wah Man; Anita K Gandhi; Tanya Svinkina; Rebekka K Schneider; Marie McConkey; Marcus Järås; Elizabeth Griffiths; Meir Wetzler; Lars Bullinger; Brian E Cathers; Steven A Carr; Rajesh Chopra; Benjamin L Ebert
Journal:  Nature       Date:  2015-07-01       Impact factor: 49.962

9.  Genome-scale analysis identifies paralog lethality as a vulnerability of chromosome 1p loss in cancer.

Authors:  Srinivas R Viswanathan; Marina F Nogueira; Colin G Buss; John M Krill-Burger; Mathias J Wawer; Edyta Malolepsza; Ashton C Berger; Peter S Choi; Juliann Shih; Alison M Taylor; Benjamin Tanenbaum; Chandra Sekhar Pedamallu; Andrew D Cherniack; Pablo Tamayo; Craig A Strathdee; Kasper Lage; Steven A Carr; Monica Schenone; Sangeeta N Bhatia; Francisca Vazquez; Aviad Tsherniak; William C Hahn; Matthew Meyerson
Journal:  Nat Genet       Date:  2018-06-28       Impact factor: 38.330

10.  Systematic illumination of druggable genes in cancer genomes.

Authors:  Junjie Jiang; Jiao Yuan; Zhongyi Hu; Youyou Zhang; Tianli Zhang; Mu Xu; Meixiao Long; Yi Fan; Janos L Tanyi; Kathleen T Montone; Omid Tavana; Robert H Vonderheide; Ho Man Chan; Xiaowen Hu; Lin Zhang
Journal:  Cell Rep       Date:  2022-02-22       Impact factor: 9.423
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.